ShenLingBaiZhu powder ameliorates obesity and atherosclerosis by inhibiting inflammation and apoptosis through the suppression of the TLR4/NF-κB pathway

Bibliographic Data

ID14738871
AuthorsXize Wu (0000-0002-0535-4583, Liaoning University of Traditional Chinese Medicine), Changbin Yuan (0000-0002-6323-2496, Liaoning University of Traditional Chinese Medicine), Haotian Wang (0000-0001-9783-6389, Liaoning University of Traditional Chinese Medicine), Xue Pan (0000-0003-0299-7556, Liaoning University of Traditional Chinese Medicine, corresponding author), Ruiying Wang (0000-0002-7400-7657, Liaoning University of Traditional Chinese Medicine), Qicheng Cai (Liaoning University of Traditional Chinese Medicine), Yuxi Huang (0000-0003-3356-2512, Liaoning University of Traditional Chinese Medicine), Jiaqi Ren (0000-0002-5099-9129, Liaoning University of Traditional Chinese Medicine), Jian Kang (0009-0002-5713-1776, Liaoning University of Traditional Chinese Medicine), Meijia Cheng (Liaoning University of Traditional Chinese Medicine), Xiaoyu Gao (0000-0002-4072-9969, China Medical University), Yue Li (0009-0004-9365-9070, Liaoning University of Traditional Chinese Medicine, corresponding author), Kaifeng Yu (0000-0001-5434-1386, Liaoning University of Traditional Chinese Medicine, corresponding author), Jiaxiang Pan (Liaoning University of Traditional Chinese Medicine, corresponding author)
Year2026
Volume361
Pages121247
Publication date2026-04-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2026.121247
PMID41564986
OpenAlexW7124981093
LanguageEN
References cited56